Clinical trials are built on trust: that participants meet eligibility criteria, enroll honestly, and follow protocols. But as trials become more decentralized and competitive, that assumption grows increasingly in risk.
One of the most damaging, and overlooked, forms of patient fraud is dual enrollment, where a participant enrolls in multiple trials at the same time.
Why does this matter?
Dual enrollment can:
- Confound safety and efficacy data
- Introduce unknown drug–drug interactions
- nflate adverse event and placebo rates
- Trigger regulatory scrutiny or trial invalidation
Yet many organizations still rely on manual site attestations, spreadsheets, or patient self-reporting to prevent it, approaches that simply don’t scale in today’s research environment.
The reality is that fraud prevention must move from reactive detection to proactive prevention.That means automation, real-time insight, and cross-study visibility without compromising patient privacy or slowing enrollment.
As part of the evoloution into the industry’s first Clinical Trial Success System (CTSS) ClinAsyst has embedded dual enrollment prevention directly into trial operations through our built-in patient status tracker. By monitoring participant enrollment status in real time and flagging potential conflicts before randomization, sites, sponsors, and CROs can protect data integrity without adding site burden or relying on trust alone.
Patient fraud may never disappear entirely, but its impact doesn’t have to negatively define trial outcomes. In fact, by addressing fraud before it can even occur, ClinAsyst can help sites define trial outcomes with success! Engineering integrity into clinical trials isn’t just good practice. It’s essential for delivering safer, faster, and more reliable research.
Conclusions Patient fraud is a growing threat to clinical trials, impacting data quality, timelines, and patient safety. As trials become more decentralized, sponsors and sites must adopt stronger verification and proactive monitoring to prevent fraudulent participation.
